💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Nutanix stock outlook brightens with raised price target and stable demand, notes RBC Capital

EditorAhmed Abdulazez Abdulkadir
Published 08/29/2024, 09:07 AM
NTNX
-

On Thursday, RBC Capital Markets adjusted its outlook on Nutanix (NASDAQ:NTNX) shares, raising the price target to $75 from $70, while maintaining an Outperform rating. The revision followed Nutanix's announcement of its fourth-quarter results, which surpassed consensus expectations and reached the higher end of the company's guidance.

The company's performance was marked by strong Annual Contract Value (ACV) and revenue, which were key factors in the analyst's positive stance. Despite concerns about the initial fiscal year 2025 guidance, Nutanix's solid quarterly outcomes provided a reassuring sign for investors.

RBC Capital highlighted several key points from Nutanix's report. Among them was the continuation of large deal momentum, which, while positive, introduces some unpredictability in the timing of deals. Moreover, the company's management observed stable demand in the market but also noted that sales cycles have become more protracted.

Another significant aspect underscored by the analyst was the progress of key growth drivers for Nutanix. The shift in market share from VMware (NYSE:VMW) to Nutanix is particularly notable and is seen as a continuing positive trend. This aspect of the company's strategy appears to be advancing well and contributing to its strong performance.

It was also mentioned that Nutanix management would no longer provide guidance on ACV billings, a decision that was anticipated. This change in reporting metrics aligns with the company's previously communicated expectations.

In other recent news, Nutanix, the cloud computing company, has experienced strong growth in its fiscal year-end results. The company's Q4 revenue climbed to $548 million, marking an 11% year-over-year increase, while the full-year revenue saw a 15% rise to $2.15 billion. Nutanix also reported a significant increase in its annual contract value billings and a substantial free cash flow. Following these recent developments, JPMorgan upgraded Nutanix's target price to $75, maintaining an Overweight rating on the shares.

Nutanix's fiscal year concluded with a 22% year-over-year growth in Annual Recurring Revenue (ARR) and a 21% increase in Annual Contract Value (ACV) billings. The company has also secured several large deals over the quarter, including a multimillion-dollar agreement with a Fortune 100 financial services firm.

Nutanix's outlook for fiscal year 2025 forecasts revenue between $2.435 billion and $2.465 billion, with non-GAAP operating margins of approximately 15.5% to 17%. Despite longer sales cycles and a decrease in Q4 cash balance due to the conversion of 2026 notes by Bain Capital, Nutanix remains optimistic about its future growth.

InvestingPro Insights

As RBC Capital Markets revises its outlook on Nutanix, the latest data from InvestingPro shows a company poised for growth with a robust gross profit margin of 84.55% over the last twelve months as of Q3 2024. This impressive margin underlines the company's strong financial health and efficiency in generating revenue. Additionally, Nutanix's revenue growth remains solid at 19.43% over the same period, reflecting the company's capacity to expand its market reach and sales effectively.

With Nutanix's share price having experienced a notable 69.72% return over the last year, investors may find reassurance in the company's market performance. Moreover, the InvestingPro Tips highlight that Nutanix is expected to become profitable this year, which could further solidify investor confidence in the company's trajectory. The tips also note that Nutanix operates with a moderate level of debt, suggesting a balanced approach to leveraging and financial risk management.

For investors seeking more comprehensive analysis and additional insights, InvestingPro offers 11 tips on Nutanix, available through their platform.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.